C186H188ClFN28O15 — CID 160535939
2-[4-(adamantane-1-carbonylamino)phenyl]-N-cyclopentyl-3H-benzimidazole-5-carboxamide;2-(4-benzamidophenyl)-N-cyclopentyl-3H-benzimidazole-5-carboxamide;2-[4-[(4-chlorobenzoyl)amino]phenyl]-N-cyclopentyl-3H-benzimidazole-5-carboxamide;2-[4-(cyclohexanecarbonylamino)phenyl]-N-cyclopentyl-3H-benzimidazole-5-carboxamide;2-[4-(cyclopentanecarbonylamino)phenyl]-N-cyclopentyl-3H-benzimidazole-5-carboxamide;N-cyclopentyl-2-[4-[(4-fluorobenzoyl)amino]phenyl]-3H-benzimidazole-5-carboxamide;N-cyclopentyl-2-[4-[(4-methoxybenzoyl)amino]phenyl]-3H-benzimidazole-5-carboxamide (PubChem CID 160535939) has the molecular formula C186H188ClFN28O15 and a molecular weight of 3110.18 g/mol. Its IUPAC name is 2-[4-(adamantane-1-carbonylamino)phenyl]-N-cyclopentyl-3H-benzimidazole-5-carboxamide;2-(4-benzamidophenyl)-N-cyclopentyl-3H-benzimidazole-5-carboxamide;2-[4-[(4-chlorobenzoyl)amino]phenyl]-N-cyclopentyl-3H-benzimidazole-5-carboxamide;2-[4-(cyclohexanecarbonylamino)phenyl]-N-cyclopentyl-3H-benzimidazole-5-carboxamide;2-[4-(cyclopentanecarbonylamino)phenyl]-N-cyclopentyl-3H-benzimidazole-5-carboxamide;N-cyclopentyl-2-[4-[(4-fluorobenzoyl)amino]phenyl]-3H-benzimidazole-5-carboxamide;N-cyclopentyl-2-[4-[(4-methoxybenzoyl)amino]phenyl]-3H-benzimidazole-5-carboxamide.
| Compound Name | 2-[4-(adamantane-1-carbonylamino)phenyl]-N-cyclopentyl-3H-benzimidazole-5-carboxamide;2-(4-benzamidophenyl)-N-cyclopentyl-3H-benzimidazole-5-carboxamide;2-[4-[(4-chlorobenzoyl)amino]phenyl]-N-cyclopentyl-3H-benzimidazole-5-carboxamide;2-[4-(cyclohexanecarbonylamino)phenyl]-N-cyclopentyl-3H-benzimidazole-5-carboxamide;2-[4-(cyclopentanecarbonylamino)phenyl]-N-cyclopentyl-3H-benzimidazole-5-carboxamide;N-cyclopentyl-2-[4-[(4-fluorobenzoyl)amino]phenyl]-3H-benzimidazole-5-carboxamide;N-cyclopentyl-2-[4-[(4-methoxybenzoyl)amino]phenyl]-3H-benzimidazole-5-carboxamide |
|---|---|
| PubChem CID | 160535939 |
| Molecular Formula | C186H188ClFN28O15 |
| Molecular Weight | 3110.18 g/mol |
| Exact Mass | 3107.45 |
| IUPAC Name | 2-[4-(adamantane-1-carbonylamino)phenyl]-N-cyclopentyl-3H-benzimidazole-5-carboxamide;2-(4-benzamidophenyl)-N-cyclopentyl-3H-benzimidazole-5-carboxamide;2-[4-[(4-chlorobenzoyl)amino]phenyl]-N-cyclopentyl-3H-benzimidazole-5-carboxamide;2-[4-(cyclohexanecarbonylamino)phenyl]-N-cyclopentyl-3H-benzimidazole-5-carboxamide;2-[4-(cyclopentanecarbonylamino)phenyl]-N-cyclopentyl-3H-benzimidazole-5-carboxamide;N-cyclopentyl-2-[4-[(4-fluorobenzoyl)amino]phenyl]-3H-benzimidazole-5-carboxamide;N-cyclopentyl-2-[4-[(4-methoxybenzoyl)amino]phenyl]-3H-benzimidazole-5-carboxamide |
| SMILES | COc1ccc(C(=O)Nc2ccc(-c3nc4ccc(C(=O)NC5CCCC5)cc4[nH]3)cc2)cc1.O=C(NC1CCCC1)c1ccc2nc(-c3ccc(NC(=O)C45CC6CC(CC(C6)C4)C5)cc3)[nH]c2c1.O=C(NC1CCCC1)c1ccc2nc(-c3ccc(NC(=O)C4CCCC4)cc3)[nH]c2c1.O=C(NC1CCCC1)c1ccc2nc(-c3ccc(NC(=O)C4CCCCC4)cc3)[nH]c2c1.O=C(Nc1ccc(-c2nc3ccc(C(=O)NC4CCCC4)cc3[nH]2)cc1)c1ccc(Cl)cc1.O=C(Nc1ccc(-c2nc3ccc(C(=O)NC4CCCC4)cc3[nH]2)cc1)c1ccc(F)cc1.O=C(Nc1ccc(-c2nc3ccc(C(=O)NC4CCCC4)cc3[nH]2)cc1)c1ccccc1 |
| InChI | InChI=1S/C30H34N4O2.C27H26N4O3.C26H23ClN4O2.C26H23FN4O2.C26H30N4O2.C26H24N4O2.C25H28N4O2/c35-28(31-23-3-1-2-4-23)22-7-10-25-26(14-22)34-27(33-25)21-5-8-24(9-6-21)32-29(36)30-15-18-11-19(16-30)13-20(12-18)17-30;1-34-22-13-8-18(9-14-22)26(32)29-21-11-6-17(7-12-21)25-30-23-15-10-19(16-24(23)31-25)27(33)28-20-4-2-3-5-20;2*27-19-10-5-17(6-11-19)25(32)29-21-12-7-16(8-13-21)24-30-22-14-9-18(15-23(22)31-24)26(33)28-20-3-1-2-4-20;2*31-25(18-6-2-1-3-7-18)28-21-13-10-17(11-14-21)24-29-22-15-12-19(16-23(22)30-24)26(32)27-20-8-4-5-9-20;30-24(17-5-1-2-6-17)27-20-12-9-16(10-13-20)23-28-21-14-11-18(15-22(21)29-23)25(31)26-19-7-3-4-8-19/h5-10,14,18-20,23H,1-4,11-13,15-17H2,(H,31,35)(H,32,36)(H,33,34);6-16,20H,2-5H2,1H3,(H,28,33)(H,29,32)(H,30,31);2*5-15,20H,1-4H2,(H,28,33)(H,29,32)(H,30,31);10-16,18,20H,1-9H2,(H,27,32)(H,28,31)(H,29,30);1-3,6-7,10-16,20H,4-5,8-9H2,(H,27,32)(H,28,31)(H,29,30);9-15,17,19H,1-8H2,(H,26,31)(H,27,30)(H,28,29) |
| InChIKey | QWDRTRZEWKOZFQ-UHFFFAOYSA-N |
| XLogP | 37.93 |
| TPSA | 617.39 Ų |
| H-Bond Donors | 21 |
| H-Bond Acceptors | 22 |
| Rotatable Bonds | 36 |
| Heavy Atoms | 231 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3110.18 |
| LogP ≤ 5 | 37.93 |
| H-Bond Donors ≤ 5 | 21 |
| H-Bond Acceptors ≤ 10 | 22 |